Search - tctmd.com

Displaying 221 - 240 of 444

Sort: Relevancy | Date

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

News Daily News

‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry

Todd Neale

May 17, 2017

Presentation SCAI 2017

Watchman LAAO: Implant Procedure and Patient Management

Presenter: Chadi Alraies

May 11, 2017

News Conference News ACC 2017

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

L.A. McKeown

March 21, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Three

Shelley Wood

March 19, 2017

Presentation SIF 2017

Watchman Imaging: The Echocardiographic Assessment

Presenter: Robert F. Burke

March 09, 2017

Presentation SIF 2017

LAA Closure with the WATCHMAN Device: A Perfect Case

Presenter: Ramon Quesada,

March 09, 2017

Presentation SIF 2017

How to Perform Watchman

Presenter: Steven J Yakubov

March 09, 2017

Presentation SIF 2017

Watchman Implantation Case

Presenter: Michael J. Lim

March 09, 2017

Presentation SIF 2017

Guidelines in Choosing Optimal Patient For Watchman

Presenter: Samir Kapadia

March 09, 2017

News Daily News

More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion

Todd Neale

December 05, 2016

News Opinion Editor's Corner TCT 2016

我对 2016 年 TCT 的总结：惊喜、假设和赠品

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Shelley Wood

November 07, 2016

News Conference News

Watchman, Amulet LAA Closure Devices Carry Low Complication Rates

Todd Neale

November 04, 2016

Presentation TCT 2016

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Presenter: Martin B. Leon, Louis A. Cannon, David R. Holmes Jr.

November 02, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder

Presenter: Krzysztof Bartus, Saibal Kar

November 01, 2016

Presentation TCT 2016

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Presenter: Zahid Amin, Jacqueline Saw, Vivek Y. Reddy

October 31, 2016

Presentation TCT 2016

Real-world Watchman Outcomes: Insights From the EWOLUTION European Registry

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Martin W. Bergmann

October 30, 2016

Presentation TCT 2016

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?

Presenter: Vivek Y. Reddy, Steven J. Yakubov, David R. Holmes Jr.

October 30, 2016

Advertisement

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry

Watchman LAAO: Implant Procedure and Patient Management

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

Live From Washington: ACC 2017, Day Three

Watchman Imaging: The Echocardiographic Assessment

LAA Closure with the WATCHMAN Device: A Perfect Case

How to Perform Watchman

Watchman Implantation Case

Guidelines in Choosing Optimal Patient For Watchman

More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion

我对 2016 年 TCT 的总结：惊喜、假设和赠品

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Watchman, Amulet LAA Closure Devices Carry Low Complication Rates

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Real-world Watchman Outcomes: Insights From the EWOLUTION European Registry

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content